Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease

被引：0
|
作者：
Elżbieta Kimak
Bartosz Zięba
Dariusz Duma
Janusz Solski
机构：
[1] Medical University,Department of Laboratory Diagnostics
[2] Department of Cardiology of the Provincial Specialistics Cardinal Stefan Wyszynski Hospital,undefined
来源：
Lipids in Health and Disease | / 17卷
关键词：
Myeloperoxidase; Inflammatory markers; Lipids; Lipoproteins; Stable coronary;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
    Langseth, Miriam Sjastad
    Opstad, Trine Baur
    Bratseth, Vibeke
    Solheim, Svein
    Arnesen, Harald
    Pettersen, Alf Age
    Seljeflot, Ingebjorg
    Helseth, Ragnhild
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (07) : 762 - 769
  • [32] Active and total myeloperoxidase in coronary artery disease and relation to clinical instability
    Gach, Olivier
    Brogneaux, Cedric
    Franck, Thierry
    Serteyn, Didier
    Legrand, Victor
    Pierard, Luc A.
    Magne, Julien
    ACTA CARDIOLOGICA, 2015, 70 (05) : 522 - 527
  • [33] The influence of regular walking at different times of day on blood lipids and inflammatory markers in sedentary patients with coronary artery disease
    Lian, Xiao-Qing
    Zhao, Di
    Zhu, Meng
    Wang, Ze-Mu
    Gao, Wei
    Zhao, Huan
    Zhang, Ding-Guo
    Yang, Zhi-Jian
    Wang, Lian-Sheng
    PREVENTIVE MEDICINE, 2014, 58 : 64 - 69
  • [34] Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis
    Zeb, Irfan
    Jorgensen, Neal W.
    Blumenthal, Roger S.
    Burke, Gregory L.
    Lloyd-Jones, Donald
    Blaha, Michael J.
    Wong, Nathan D.
    Nasir, Khurram
    Budoff, Matthew J.
    ATHEROSCLEROSIS, 2021, 339 : 27 - 34
  • [35] Myeloperoxidase polymorphism and coronary artery disease risk A meta-analysis
    Wang, Yan
    Chen, Xu-Yan
    Wang, Ke
    Li, Shan
    Zhang, Xiang-Yang
    MEDICINE, 2017, 96 (27)
  • [36] Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis
    Foody, JM
    Milberg, JA
    Pearce, GL
    Sprecher, DL
    ATHEROSCLEROSIS, 2000, 153 (02) : 445 - 451
  • [37] Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
    Haraguchi, Yoko
    Toh, Ryuji
    Hasokawa, Minoru
    Nakajima, Hideto
    Honjo, Tomoyuki
    Otsui, Kazunori
    Mori, Kenta
    Miyamoto-Sasaki, Maki
    Shinohara, Masakazu
    Nishimura, Kunihiro
    Ishida, Tatsuro
    Hirata, Ken-ichi
    ATHEROSCLEROSIS, 2014, 234 (02) : 288 - 294
  • [38] THE ROLE OF LIPOPROTEIN A-I AND LIPOPROTEIN A-I/A-II IN PREDICTING CORONARY-ARTERY DISEASE
    OBRIEN, T
    NGUYEN, TT
    HALLAWAY, BJ
    HODGE, D
    BAILEY, K
    HOLMES, D
    KOTTKE, BA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (02) : 228 - 231
  • [39] The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture
    Teng, Nathaniel
    Maghzal, Ghassan J.
    Talib, Jihan
    Rashid, Imran
    Lau, Antony K.
    Stocker, Roland
    REDOX REPORT, 2017, 22 (02) : 51 - 73
  • [40] Lipid profiles in nontreated Chinese patients with stable coronary artery disease: a cross-sectional study
    Li, Sha
    Ye, Ping
    Chen, Hong
    Li, Yan-Fang
    Hua, Qi
    Zhang, Yan
    Xu, Rui-Xia
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    CLINICAL LIPIDOLOGY, 2015, 10 (05) : 369 - 378
12345